Government Plan to Expand Medicare HIV Coverage Is Dropped

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 1
Volume 7
Issue 1

WASHINGTON-The Clinton administration has decided not to extend Medicaid coverage to all low-income people infected with HIV. Currently, HIV-positive patients who have developed AIDS can receive Medicaid benefits even if they are not poor enough to qualify under normal Medicaid guidelines.

WASHINGTON—The Clinton administration has decided not to extend Medicaid coverage to all low-income people infected with HIV. Currently, HIV-positive patients who have developed AIDS can receive Medicaid benefits even if they are not poor enough to qualify under normal Medicaid guidelines.

The administration had speculated that extending the AIDS exception would be cost effective by allowing HIV-positive patients to receive the newer HIV drug combinations that may prevent progression to AIDS.

However, Victor Zonana, a spokesman for the Department of Health and Human Services, said that none of the proposals for the expansion analyzed by the government yielded a “revenue-neutral” plan, that is, one that would not increase spending over a 5-year period.

Although the administration has declined to make the change nationwide, individual states have the option of developing and submitting their own proposals for such a change, if they can be shown not to increase costs. According to Mr. Zonana, at least three states—Maine, Massachusetts, and Florida—have expressed an interest in doing so.

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content